BRANY Members Benefit from Streamlined Patient Payment System
BRANY (Biomedical Research Alliance of New York) research sites now have the opportunity to improve their patient stipend payments and manage their study budgets with a discount from Greenphire’s ClinCard System.
The ClinCard System is a fully configurable and primarily web-based technology, designed to comply with all applicable regulation and enabling sites and sponsors to deliver subject payments (stipends, travel reimbursements, and other ad-hoc payments) in a controlled and automated manner in compliance with industry regulation and in accordance with the specific requirements of each study.
“BRANY’s partnership with Greenphire is a natural extension of our suite of services to our alliance members,” says BRANY’s Carmela Houston-Henry, Director of Sales and Business Development. “Our members benefit from efficiency in managing their study budgets, and study participants receive expedited stipend payments.”
Recently Montefiore Medical Center, the University Hospital for Albert Einstein College of Medicine became the 100th study site to implement the ClinCard system. Montefiore joins a large and established base of sites and more than 20 sponsors and CROs in realizing the ClinCard’s benefits to the clinical trials process. By automating patient stipend payments, reimbursements, and communication through a web-based portal, Greenphire’s innovative technologies enhance the patient experience and improve patient retention, reduce administration associated with patient payments and communication for both site and sponsor users, and centralize reporting, tracking, and auditing of stipends and reimbursements.
The Biomedical Research Alliance of New York (BRANY) is a national organization providing support services to sponsors and investigators involved in research in a wide variety of therapeutic areas, medical devices, biologic and diagnostic trials. Staffed by multi-disciplinary experts, BRANY is an expedited "end-to-end solution" for clinical trials.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
